Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00670332 · ClinicalTrials.gov registry record

Prognostic Assessment of Contrast Echocardiography (PACE Study)

A clinical trial, sponsored by Acusphere.

Terminated
Registry status
773
Enrollment target

NCT00670332: Clinical Trial study, sponsored by Acusphere.

NCT00670332 is a clinical trial that was terminated before completion, run by Acusphere. The registered enrollment target is 773 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00670332 was terminated before completion, sponsored by Acusphere.

TERMINATED
Registry status
773 participants
Enrollment target

Study Summary

This study will demonstrate whether patients with prognostically-significant myocardial abnormalities detected with AI-700 contrast ECHO have a rate of cardiac death or MI that is higher than that of patients with normal AI-700 contrast ECHO.

Trial Details

FieldValue
Enrollment Target 773 participants
Start Date 2007-07
Acusphere

5 total trials

Why NCT00670332 stopped before completion

NCT00670332 is an observational study that tracks outcomes without assigning an intervention. The registered 773 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00670332 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00670332 about?

NCT00670332 is a clinical study titled "Prognostic Assessment of Contrast Echocardiography (PACE Study)". This study will demonstrate whether patients with prognostically-significant myocardial abnormalities detected with AI-700 contrast ECHO have a rate of cardiac death or MI that is higher than that of patients with normal AI-700 contrast ECHO.

What is the current status of trial NCT00670332?

This trial is currently terminated. The enrollment target is 773 participants. The study started on 2007-07.

Who is sponsoring clinical trial NCT00670332?

This trial is sponsored by Acusphere, which has 5 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03460769 · 775 participants

    Evaluation of a Mixed Meal Test for Diagnosis and Characterization and Type 3c Diabetes Mellitus Secondary to Pancreatic Cancer and Chronic Pancreatitis (DETECT)

  • NCT06145763 · 776 participants · NA

    A Digital Smoking Cessation Intervention for Helping American Indians and Alaska Natives Quit Smoking, IndigeQuit Trial

  • NCT05977348 · 770 participants · NA

    Increasing Food Literacy in Preschoolers to Reduce Obesity Risk

  • NCT06376994 · 770 participants · Phase 3

    Multi-Center Clean Air Randomized Controlled Trial in COPD

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00670332, the US trial registry maintained by the National Library of Medicine. NCT00670332 (mid enrollment · none site footprint · terminated) retrieved and formatted by PlainTrial, see methodology.